Variant report
Variant | nsv522059 |
---|---|
Chromosome Location | chr14:42467597-42477256 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:42462776..42464890-chr14:42474456..42476281,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189773972 | chr14:42469206-42469207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554680559 | chr14:42469213-42469214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34365942 | chr14:42469221-42469222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12893514 | chr14:42469243-42469244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150461269 | chr14:42469260-42469261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368018015 | chr14:42469320-42469321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560131194 | chr14:42469325-42469326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558868034 | chr14:42469326-42469327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577469145 | chr14:42469335-42469336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544860229 | chr14:42469345-42469346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138293045 | chr14:42469351-42469352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566006384 | chr14:42469479-42469480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111516732 | chr14:42469517-42469518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542419621 | chr14:42469556-42469557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1601593 | chr14:42469567-42469568 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs149612916 | chr14:42469595-42469596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201759198 | chr14:42469609-42469610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1614577 | chr14:42469611-42469612 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs569749706 | chr14:42469723-42469724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528498385 | chr14:42469766-42469767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181753574 | chr14:42469770-42469771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532327132 | chr14:42469784-42469785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550819537 | chr14:42469799-42469800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140141410 | chr14:42469815-42469816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568796856 | chr14:42469833-42469834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs8019977 | chr14:42469834-42469835 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs186240973 | chr14:42469870-42469871 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192097602 | chr14:42469871-42469872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567117328 | chr14:42469884-42469885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534248458 | chr14:42469917-42469918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1624840 | chr14:42470003-42470004 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs577132645 | chr14:42470015-42470016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146167769 | chr14:42470057-42470058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556844098 | chr14:42470126-42470127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71440765 | chr14:42470136-42470137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs398118117 | chr14:42470149-42470150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373724643 | chr14:42470150-42470151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556946395 | chr14:42470171-42470172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368774835 | chr14:42470219-42470220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575206568 | chr14:42470224-42470225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542483009 | chr14:42470235-42470236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183596875 | chr14:42470255-42470256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577053155 | chr14:42470276-42470277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112590497 | chr14:42470381-42470382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74539082 | chr14:42470395-42470396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188481496 | chr14:42470402-42470403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532169295 | chr14:42470411-42470412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201685759 | chr14:42470479-42470480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74920669 | chr14:42470530-42470531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546147774 | chr14:42470538-42470539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:42469200-42469800 | Enhancers | Hela-S3 | cervix |
2 | chr14:42469400-42469600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr14:42469800-42470000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr14:42469800-42470200 | Weak transcription | Hela-S3 | cervix |
5 | chr14:42469800-42471000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr14:42470200-42472000 | Enhancers | Hela-S3 | cervix |
7 | chr14:42470800-42471600 | Enhancers | Placenta Amnion | Placenta Amnion |
8 | chr14:42470800-42471600 | Enhancers | A549 | lung |
9 | chr14:42471000-42471800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr14:42471400-42471800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr14:42471600-42471800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr14:42473000-42473200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |